Menu
Not yet recruiting NCT07471243

Dressing-related Experiences and Surgical Site Self-care in Hip and Knee Replacement: an Observational Cohort Study

Observational Total Hip Replacement Total Knee Replacement

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Wound Dressing Material.
Who it may be relevant to
Registry conditions: Total Hip Replacement, Total Knee Replacement. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Dressing-Related Experiences and Surgical Site Self-Care in Hip and Knee Replacement: an Observational Cohort Study (DRESS-X)

Overview

The goal of this prospective observational cohort study is to investigate dressing-related experiences and surgical site self-care in patients who are undergoing a total hip or knee replacement. The main objectives of the study are: * To evaluate patient adherence to the ISWCAP self-care checklist after total hip or knee replacement within an ERAS pathway. * To explore patient-reported outcomes related to the performance and comfort of advanced dressings. * To assess the perceived adequacy and usefulness of post-discharge wound care education. * To identify the incidence and types of wound-related complications in the 12 weeks following surgery. Participants will give informed consent before surgery and will start the study once the dressing has been applied following surgery. There will be follow up study visits at discharge, 7 days, 12 days, 6 weeks and 12 weeks post-surgery. Data relating to vital signs, medical history, surgery and medication will be taken from routine data.

Interventions

  • Other Wound Dressing Material
    The study will investigate any wound dressing applied as part of routine care. Advanced wound dressings are highly absorbent, flexible and comfortable for surgical wounds, and offer up to 14 days wear time. The adhesive moulds to the skin without sticking to the wound, thus protecting the skin and wound from damage. They support patient mobilisation by being comfortable, and thereby minimising painful skin damage such as blisters.

Primary outcome measures

  • The proportion of participants responding "yes" to each item of the ISWCAP checklist at 6-weeks post-surgery [Time frame: 6-weeks post surgery]
Secondary outcome measures (3)
  • Incidence and types of wound complications such as infection, dehiscence (as measured by the Sandy Grading System for surgical wound dehiscence classification), and blistering in the 12-weeks following surgery [Time frame: From surgery until the 12-week follow-up appointment]
  • Bluebelle Wound Healing Questionnaire, completed at Visits 5 (12-days post-surgery) and 6 (6-weeks post-surgery) [Time frame: 12-days post-surgery and 6-weeks post-surgery]
  • Dressing Comfort and Usability Survey completed at Visits 4 (7-days post-surgery) and 5 (12-days post-surgery) [Time frame: 7- and 12-days post-surgery]

Eligibility criteria

Inclusion criteria

  • Adults (18+) undergoing primary total hip or knee replacement
  • Enrolled in an ERAS protocol
  • Willing and able to provide informed consent

Exclusion criteria

  • Requiring revision replacement
  • Unable to provide informed consent (cognitive disorder such as dementia, psychiatric illness)
  • Unable to understand written English

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United Kingdom · 2 centers
  • Nuffield Health Hospital Bournemouth — Bournemouth
  • Bournemouth University — Bournemouth

Identifiers

NCT: NCT07471243 · ORI/14918/25

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗